[TLX] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
29-Jun-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -0.96%
YoY-
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/00 30/06/99 CAGR
Revenue 2,910 1,607 1,818 49 0 0 0 -100.00%
PBT -37,046 -25,096 -17,125 -5,190 -1,571 -124 -72 -7.68%
Tax -4,532 -6,795 -6,756 -471 -38 -124 -72 -5.16%
NP -32,514 -18,301 -10,370 -5,190 -1,571 0 0 -100.00%
Tax Rate - - - - - - - -
Total Cost 35,424 19,908 12,187 5,239 1,571 0 0 -100.00%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/00 30/06/99 CAGR
NP Margin -1,117.32 -1,138.83 -570.54 -10,638.53 0.00 0.00 0.00 -100.00%
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/00 30/06/99 CAGR
EPS -0.12 -0.07 -0.05 -0.03 -0.64 0.00 0.00 -100.00%
EPS Diluted -0.12 -0.07 -0.05 -0.03 -0.64 0.00 0.00 -100.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.